Illuminating CNS and cognitive issues in myotonic dystrophy: Workshop report

Neuromuscular Disorders

Volumn 23, Issue 4, 2013, Pages 370-374

  Axford, Michelle M ^a,b   Pearson, Christopher E ^a,b  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; RNA; TAU PROTEIN;

APATHY; ARTICLE; CENTRAL NERVOUS SYSTEM DISEASE; COGNITIVE DEFECT; DISEASE MODEL; EMPLOYMENT STATUS; FATIGUE; HUMAN; MEDICAL RESEARCH; MYOTONIC DYSTROPHY; NERVE DEGENERATION; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RNA SPLICING; RNA TRANSLATION; SLEEP DISORDER; SOCIAL DISABILITY; SYMPTOM; TAUOPATHY; WORKSHOP;

ANIMALS; CENTRAL NERVOUS SYSTEM DISEASES; COGNITION DISORDERS; DISEASE MODELS, ANIMAL; HUMANS; MYOTONIC DYSTROPHY;

EID: 84874954379     PISSN: 09608966     EISSN: 18732364     Source Type: Journal    
DOI: 10.1016/j.nmd.2013.01.003     Document Type: Article

References (11)

1. Meola G., Sansone V. Cerebral involvement in myotonic dystrophies. Muscle Nerve 2007 Sep, 36(3):294-306.
2. Caramia F., Mainero C., Gragnani F. Functional MRI changes in the central motor system in myotonic dystrophy type 1. Magn Reson Imaging 2010, 28(2):226-234.
3. Minnerop M., Weber B., Schoene-Bake J.C., et al. The brain in myotonic dystrophy 1 and 2: evidence for a predominant white matter disease. Brain 2011, 134(Pt 12):3530-3546.
4. Romeo V., Pegoraro E., Ferrati C. Brain involvement in myotonic dystrophies: neuroimaging and neuropsychological comparative study in DM1 and DM2. J Neurol 2010, 257(8):1246-1255.
5. Di Costanzo A., de Cristofaro M., Di Iorio G. Paternally inherited case of congenital DM1: brain MRI and review of literature. Brain Dev 2009, 31(1):79-82.
6. Charizanis K., Lee K.Y., Batra R. Muscleblind-like 2-mediated alternative splicing in the developing brain and dysregulation in myotonic dystrophy. Neuron 2012, 75(3):437-450.
7. Zu T., Gibbens B., Doty N.S. Non-ATG-initiated translation directed by microsatellite expansions. Proc Natl Acad Sci USA 2011, 108(1):260-265.
8. Pearson C.E. Repeat associated non-ATG translation initiation: one DNA, two transcripts, seven reading frames, potentially nine toxic entities!. PLoS Genet 2011, 7(3):e1002018.
9. Gomes-Pereira M., Cooper T.A., Gourdon G. Myotonic dystrophy mouse models: towards rational therapy development. Trends Mol Med 2011, 17(9):506-517.
10. Maurage C.A., Udd B., Ruchoux M.M., et al. Similar brain tau pathology in DM2/PROMM and DM1/Steinert disease. Neurology 2005, 65:1636-1638.
11. Itoh K., Mitani M., Kawamoto K. Neuropathology does not correlate with regional differences in the extent of expansion of CTG repeats in the brain with myotonic dystrophy type 1. Acta Histochem Cytochem 2010, 43:149-156.